Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Options for Severe Peritonitis

By HospiMedica staff writers
Posted on 19 Sep 2007
Performing a repeat surgery (relaparotomy) for patients with peritonitis only when clinical improvement is lacking may have some advantages compared with having the repeat procedure routinely scheduled after the operation, according to a new study.

Researchers from the Academic Medical Center (Amsterdam, The Netherlands) conducted a randomized trial comparing the on-demand strategy with the planned relaparotomy strategy following initial emergency surgery for patients with severe secondary peritonitis. More...
The clinical trial was conducted at two academic and five regional teaching hospitals in the Netherlands from November 2001 through February 2005. A total of 232 patients (116 on-demand and 116 planned) were included.

The researchers found that there was no significant difference in death and/or peritonitis-related illness within a 12-month follow-up period. A total of 4% of the on-demand patients had relaparotomy vs. 94% of the planned relaparotomy group. Patients in the on-demand group had shorter median (midpoint) intensive care unit (ICU) stays (7 vs. 11 days) and shorter median hospital stays (27 vs. 35 days). The study was published study in the August 22, 2007 issue of the Journal of the American Medical Association (JAMA).

"This randomized trial found that compared with planned relaparotomy, the on-demand strategy did not result in statistically significant reductions in the primary outcomes of death or major peritonitis-related morbidity but did result in significant reductions in the secondary outcomes of healthcare utilization, including the number of relaparotomies, the use of percutaneous drainage, and hospital and ICU stay,” concluded lead author Oddeke van Ruler, M.D., and colleagues. "Despite a lack of statistically significant improvement in primary clinical outcome, these substantial reductions in healthcare utilization and costs with the on-demand strategy suggest that it may be the preferred strategy.”

Secondary peritonitis has a high rate of death (20-60%), long hospital stays, and a high rate of illness due to the development of sepsis with multiple organ failure. Approximately 12-16% of patients undergoing elective abdominal surgery develop postoperative peritonitis.


Related Links:
Academic Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.